Shortly after we posted about Moderna, Inc.’s October 2020 pledge not to enforce its COVID-19-related patents during the pandemic, the
Continue Reading The mRNA Patent and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I
Bigfoot Biomedical® Secures up to $57 Million in Financing from Madryn Asset Management
Bigfoot Biomedical®, a Milpitas, CA emerging company, recently announced that it has secured new financing of up to $57
Continue Reading Bigfoot Biomedical® Secures up to $57 Million in Financing from Madryn Asset Management
Intent-to-Use Applications: Pros and Cons
Owning a federal trademark registration provides the ability to exclude others from using a certain word or design in association
Continue Reading Intent-to-Use Applications: Pros and Cons
IP Assignment Considerations for Emerging Companies
Founders of emerging companies must decide early on in their company’s growth cycle whether to require employees to assign their
Continue Reading IP Assignment Considerations for Emerging Companies
Considerations for Protecting your Invention with Provisional Patent Applications
Since the U.S. patent law switched to the first-inventor-to-file system in 2013, provisional applications have become more popular as the
Continue Reading Considerations for Protecting your Invention with Provisional Patent Applications
Dana-Farber Launches New Fund to Support Oncology Startups
2021 started off well for Dana-Farber Cancer Institute, with the launch of its new venture fund, Binney Street Capital,
Continue Reading Dana-Farber Launches New Fund to Support Oncology Startups
Microsoft Partners with Broad Institute and Verily to Expand Terra Platform for Biomedical Research
On January 11, 2020, the Broad Institute, Verily Life Sciences, and Microsoft announced a strategic partnership to accelerate biomedical innovations
Continue Reading Microsoft Partners with Broad Institute and Verily to Expand Terra Platform for Biomedical Research
Practice Tips: Fair Use of a Trademark (Part II)
Sometimes it is necessary to use a third-party trademark to refer to the owner of a trademark or its goods
Continue Reading Practice Tips: Fair Use of a Trademark (Part II)
Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development
Earlier this week, Biogen and ViGeneron signed a global collaboration and licensing agreement to develop gene therapies for inherited eye
Continue Reading Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development
The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics
The Italian pharmaceutical company Angelini Pharma announced on January 4, 2021, that it will acquire emerging Swiss biotech company
Continue Reading The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics